In addition, patients with invasive ductal breast carcinoma show decreased TPM4 expression compared with patients with ductal breast carcinoma in situ, and low TPM4 expression is associated with poor prognosis. The gene discussed is TPM4; the disease is ductal breast carcinoma in situ.